ES8501755A1 - Procedimiento para la obtencion de 2-piridil-indoles n-sustituidos. - Google Patents

Procedimiento para la obtencion de 2-piridil-indoles n-sustituidos.

Info

Publication number
ES8501755A1
ES8501755A1 ES517439A ES517439A ES8501755A1 ES 8501755 A1 ES8501755 A1 ES 8501755A1 ES 517439 A ES517439 A ES 517439A ES 517439 A ES517439 A ES 517439A ES 8501755 A1 ES8501755 A1 ES 8501755A1
Authority
ES
Spain
Prior art keywords
phenylene
alkylene
thio
oxy
carboxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES517439A
Other languages
English (en)
Other versions
ES517439A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES8501755A1 publication Critical patent/ES8501755A1/es
Publication of ES517439A0 publication Critical patent/ES517439A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 2-PIRIDIL-INDOLES-N-SUSTITUIDOS, DE FORMULA GENERAL (I), Y SUS SALES FARMACEUTICAMENTE ACEPTABLES.CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA GENERAL (II), CON UN COMPUESTO DE FORMULA (III).DE APLICACION COMO AGENTES DIURETICOS PARA EL TRATAMIENTO Y PREVENCION DE ENFERMEDADES CARDIOVASCULARES, TALES COMO TROMBOSIS, ARTERIOESCLEROSIS, ESPASMOS CORONARIOS, ARRITMIAS, ATAQUES CEREBRALES Y OTRAS CEFALEAS VASCULARES.
ES517439A 1981-11-19 1982-11-17 Procedimiento para la obtencion de 2-piridil-indoles n-sustituidos. Granted ES517439A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32301881A 1981-11-19 1981-11-19

Publications (2)

Publication Number Publication Date
ES8501755A1 true ES8501755A1 (es) 1984-12-01
ES517439A0 ES517439A0 (es) 1984-12-01

Family

ID=23257445

Family Applications (4)

Application Number Title Priority Date Filing Date
ES517439A Granted ES517439A0 (es) 1981-11-19 1982-11-17 Procedimiento para la obtencion de 2-piridil-indoles n-sustituidos.
ES530127A Expired ES8608508A1 (es) 1981-11-19 1984-02-28 Procedimiento para la obtencion de 2-piridil-indoles n-sustituidos
ES530126A Expired ES8601962A1 (es) 1981-11-19 1984-02-28 Procedimiento para la obtencion de 2-piridil-indoles n-sustituidos
ES530128A Expired ES8602750A1 (es) 1981-11-19 1984-02-28 Procedimiento para la obtencion de 2-piridil-indoles n-sustituidos

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES530127A Expired ES8608508A1 (es) 1981-11-19 1984-02-28 Procedimiento para la obtencion de 2-piridil-indoles n-sustituidos
ES530126A Expired ES8601962A1 (es) 1981-11-19 1984-02-28 Procedimiento para la obtencion de 2-piridil-indoles n-sustituidos
ES530128A Expired ES8602750A1 (es) 1981-11-19 1984-02-28 Procedimiento para la obtencion de 2-piridil-indoles n-sustituidos

Country Status (22)

Country Link
EP (1) EP0080154B1 (es)
JP (1) JPS5892677A (es)
KR (1) KR880002010B1 (es)
AR (3) AR241428A1 (es)
AT (1) ATE15196T1 (es)
AU (1) AU564233B2 (es)
CA (1) CA1197249A (es)
DD (1) DD204924A5 (es)
DE (1) DE3265892D1 (es)
DK (1) DK169104B1 (es)
ES (4) ES517439A0 (es)
FI (1) FI75344C (es)
GB (1) GB2111050B (es)
GR (1) GR77035B (es)
HU (1) HU190425B (es)
IE (1) IE54156B1 (es)
IL (1) IL67284A (es)
NO (1) NO159929C (es)
NZ (1) NZ202551A (es)
PH (1) PH19212A (es)
PT (1) PT75870B (es)
ZA (1) ZA828505B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides
US4675332A (en) * 1984-12-10 1987-06-23 Warner-Lambert Company Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
US4609733A (en) * 1984-12-27 1986-09-02 Ciba-Geigy Corporation 3-keto-substituted-N-pyridylindoles
GB8626297D0 (en) * 1986-11-04 1986-12-03 Ici Plc Pharmaceutical compositions
GB8626296D0 (en) * 1986-11-04 1986-12-03 Ici Plc Therapeutic agents
GB9319100D0 (en) * 1993-09-15 1993-11-03 Pfizer Ltd 3-(3-pyridinyl)h-indoles
CA2140722A1 (en) * 1994-01-24 1995-07-25 Joseph A. Jakubowski Beta-carboline thromboxane synthase inhibitors
US6828344B1 (en) * 1998-02-25 2004-12-07 Genetics Institute, Llc Inhibitors of phospholipase enzymes
GB0307891D0 (en) * 2003-04-04 2003-05-14 Angeletti P Ist Richerche Bio Chemical compounds,compositions and uses
AR072297A1 (es) * 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
EA202091477A1 (ru) * 2017-12-15 2020-10-28 Бристол-Маерс Сквибб Компани Замещенные соединения простых индольных эфиров

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468894A (en) * 1966-11-29 1969-09-23 Geigy Chem Corp Certain 2-pyridyl-substituted indole derivatives
DE2909779A1 (de) * 1979-03-13 1980-09-18 Thomae Gmbh Dr K Neue indolderivate, deren herstellung und deren verwendung als arzneimittel

Also Published As

Publication number Publication date
ATE15196T1 (de) 1985-09-15
NO823869L (no) 1983-05-20
ES530126A0 (es) 1985-11-16
AR243519A1 (es) 1993-08-31
FI75344B (fi) 1988-02-29
FI823938L (fi) 1983-05-20
AR241428A1 (es) 1992-07-31
ES517439A0 (es) 1984-12-01
IL67284A (en) 1986-03-31
DE3265892D1 (en) 1985-10-03
PH19212A (en) 1986-02-04
CA1197249A (en) 1985-11-26
GB2111050A (en) 1983-06-29
EP0080154A2 (de) 1983-06-01
EP0080154A3 (en) 1983-09-28
GB2111050B (en) 1985-09-11
ES530127A0 (es) 1986-06-16
IE54156B1 (en) 1989-07-05
AR243177A1 (es) 1993-07-30
ES530128A0 (es) 1985-12-01
ES8602750A1 (es) 1985-12-01
DK169104B1 (da) 1994-08-15
DD204924A5 (de) 1983-12-14
AU9067582A (en) 1983-05-26
AU564233B2 (en) 1987-08-06
PT75870A (en) 1982-12-01
ES8608508A1 (es) 1986-06-16
NZ202551A (en) 1985-11-08
EP0080154B1 (de) 1985-08-28
DK514182A (da) 1983-05-20
NO159929C (no) 1989-02-22
KR840002368A (ko) 1984-06-25
ES8601962A1 (es) 1985-11-16
GR77035B (es) 1984-09-04
NO159929B (no) 1988-11-14
PT75870B (en) 1986-01-21
FI75344C (fi) 1988-06-09
JPH029031B2 (es) 1990-02-28
KR880002010B1 (ko) 1988-10-12
JPS5892677A (ja) 1983-06-02
ZA828505B (en) 1983-09-28
FI823938A0 (fi) 1982-11-17
HU190425B (en) 1986-09-29

Similar Documents

Publication Publication Date Title
ES8608508A1 (es) Procedimiento para la obtencion de 2-piridil-indoles n-sustituidos
DK323688D0 (da) Pyridinforbindelser
ES8800682A1 (es) Un procedimiento para la preparacion de nuevas (4-piperidinilmetil y heteropurinas)
ES8606286A1 (es) Procedimiento para preparar nuevos derivados de benzazocinona y de benzazoninona
NO883146D0 (no) Anti-inflamatorisk aktive arylderivater og fremgangsmaate for deres fremstilling.
MY105158A (en) Substituted 4-aminoquinoline derivatives as gastric acid secretion inhibutors.
MA24349A1 (fr) Procede pour la preparation de derives d'indole nouveaux et pour la preparation de compositions pharmaceutiques les contenant.
ES8305755A1 (es) Procedimiento para preparar derivados de pirimidona.
ES8600276A1 (es) Procedimiento para preparar nuevos n-sustituido-2-(1-imidazolil)-indoles
ES8305355A1 (es) Un procedimiento para la preparacion de derivados del indol.
ES8303427A1 (es) "un procedimiento para preparar compuestos de cefem".
ES8609318A1 (es) Procedimiento para la obtencion de derivados de imidazol (i,5-a)-piridina
ES8706628A1 (es) Procedimiento para la preparacion de 2-(piridil e imidazolil)-indoles.
ES8802222A1 (es) Un procedimiento para preparar derivados de vinilisoquinolina
ES8401069A1 (es) Procedimiento para la obtencion de imidazo 1,5-a piridinas.
DE69315307D1 (de) Chimuclidine Derivate als Squalen synthetase Inhibitoren
IE832830L (en) Benzofuran derivatives.
IL103587A0 (en) Heterocyclic compounds
IL99777A0 (en) Indole derivatives,processes for their preparation and pharmaceutical compositions containing them
ES8601969A1 (es) Un procedimiento para preparar derivados de piridona
FI894125A (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisen 3-piperidinyyli-indatsolin valmistamiseksi
DK664888D0 (da) Cyclooctanforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende en saadan forbindelse
ES8405409A1 (es) Un procedimiento para la preparacion de derivados de b-lactama.
ES2001590A6 (es) Procedimiento para la obtencion de nuevos derivados de hidroxipiridina
ES8604392A1 (es) Un procedimiento para preparar derivados de pirazinona.

Legal Events

Date Code Title Description
PC1A Transfer granted